PRESS RELEASE published on 10/02/2023 at 17:40, 2 years 7 months ago VALBIOTIS SA: the Phase II/III REVERSE-IT study selected for an oral presentation at the 2023 EASD congress, the main European learned society for diabetes
PRESS RELEASE published on 10/02/2023 at 17:40, 2 years 7 months ago VALBIOTIS SA : l’étude de Phase II/III REVERSE-IT sélectionnée pour une présentation orale au congrès 2023 de l’EASD, principale société savante européenne pour le diabète
PRESS RELEASE published on 09/28/2023 at 17:40, 2 years 7 months ago Valbiotis publishes its financial report for the first half of 2023 and confirms its strategic roadmap
PRESS RELEASE published on 09/28/2023 at 17:40, 2 years 7 months ago Valbiotis publie son rapport financier pour le premier semestre 2023 et confirme sa feuille de route stratégique
PRESS RELEASE published on 09/11/2023 at 17:40, 2 years 8 months ago VALBIOTIS SA: Valbiotis presents the full results of the Phase II/III REVERSE-IT study: impressive efficacy of TOTUM•63 against prediabetes and the early stages of type 2 diabetes
PRESS RELEASE published on 09/11/2023 at 17:40, 2 years 8 months ago VALBIOTIS SA: Valbiotis présente les résultats complets de l’étude de Phase II/III REVERSE-IT : efficacité remarquable de TOTUM•63 contre le prédiabète et les stades précoces du diabète de type 2
PRESS RELEASE published on 09/06/2023 at 17:40, 2 years 8 months ago VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social - Juillet 2023
PRESS RELEASE published on 09/06/2023 at 17:40, 2 years 8 months ago VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social - Août 2023
PRESS RELEASE published on 08/04/2023 at 17:40, 2 years 9 months ago VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social - Juillet 2023
PRESS RELEASE published on 07/17/2023 at 17:40, 2 years 9 months ago VALBIOTIS SA: Bilan semestriel du contrat de liquidité
Published on 05/16/2026 at 01:15, 13 hours 3 minutes ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 14 hours 18 minutes ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 15 hours 8 minutes ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 15 hours 18 minutes ago Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency
Published on 05/15/2026 at 20:10, 18 hours 8 minutes ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 20 hours 7 minutes ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 17:33, 20 hours 44 minutes ago Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Published on 05/15/2026 at 15:08, 23 hours 10 minutes ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 23 hours 18 minutes ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 1 day 4 hours ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 2 days 5 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 2 days 20 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
